CollPlant Biotechnologies (CLGN) FCF Margin (QoQ) (2018 - 2025)

CollPlant Biotechnologies (CLGN) FCF Margin (QoQ) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 CollPlant Biotechnologies 4.63 Mn 4.63 Mn -243,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -113,160.00
Sep 30, 2025 -237,361.00
Dec 31, 2024 8.06 Mn
Sep 30, 2024 -8.12 Mn
Jun 30, 2024 173,933.00
Mar 31, 2024 -252,802.00
Dec 31, 2023 -70,771.00
Sep 30, 2023 3,347.00
Jun 30, 2023 72,983.00
Mar 31, 2023 2.07 Mn
Dec 31, 2022 -1.88 Mn
Sep 30, 2022 277,510.00
Dec 31, 2021 126,000.00
Sep 30, 2021 -112,588.00
Jun 30, 2021 -53,165.00
Mar 31, 2021 14,299.00
Dec 31, 2020 -3.80 Mn
Sep 30, 2020 3.82 Mn
Jun 30, 2020 21,646.00
Mar 31, 2020 -11,393.00